- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 339/04 - Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid
Patent holdings for IPC class C07D 339/04
Total number of patents in this class: 161
10-year publication summary
|
31
|
10
|
13
|
7
|
10
|
13
|
18
|
9
|
6
|
1
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Cellix Bio Private Limited | 67 |
13 |
| Cellixbio Private Limited | 167 |
7 |
| Antibe Therapeutics Inc. | 22 |
6 |
| Novartis AG | 11238 |
5 |
| Exerkine Corporation | 32 |
5 |
| Krisani Biosciences (P) Ltd | 8 |
5 |
| Research Foundation of the City University of New York | 395 |
5 |
| Ischemix LLC | 16 |
4 |
| C.t.g. Pharma S.r.l. | 11 |
3 |
| Encore Health, LLC | 16 |
3 |
| The Government of the United States of America, as represented by the Secretary of the Navy | 1102 |
3 |
| Indigene Pharmaceuticals, Inc. | 9 |
3 |
| Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. | 59 |
3 |
| Nou-life Sciences, Inc. | 3 |
3 |
| Prous Institute for Biomedical Research, S.A. | 9 |
3 |
| Santen Pharmaceutical Co., Ltd. | 649 |
3 |
| The United States of America as represented by the Secretary of the Navy | 2734 |
2 |
| The General Hospital Corporation | 4517 |
2 |
| Agfa-Gevaert | 282 |
2 |
| Alnylam Pharmaceuticals, Inc. | 1066 |
2 |
| Other owners | 79 |